Balanced News: Sysmex says Japan approves blood test kit for Alzheimer’s marker

The kit measures accumulation of a protein that is a marker for the disease – a rare advance in tackling a condition that affects millions worldwide. Japan’s Sysmex Corp says it has received regulatory approval in Japan for a blood test to detect amyloid beta in the brain, a characteristic of Alzheimer’s disease. The kit uses a small amount of the patient’s blood to measure amyloid beta accumulation in the brain, allowing for earlier diagnosis and treatment.